Linezolid: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
k →top |
Tidak ada ringkasan suntingan |
||
Baris 120:
Linezolid ditemukan pada pertengahan 1990-an. Obat ini mendapat persetujuan untuk dipasarkan pada tahun 2000.<ref>{{cite book| vauthors = Li JJ, Corey EJ |title=Drug Discovery: Practices, Processes, and Perspectives|date=2013|publisher=John Wiley & Sons|isbn=978-1-118-35446-9|page=6|url=https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6|language=en|url-status=live|archive-url=https://web.archive.org/web/20170910172617/https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6|archive-date=10 September 2017}}</ref><ref>{{cite book|last1=Torok|first1=Estee|last2=Moran|first2=Ed|last3=Cooke|first3=Fiona | name-list-format = vanc |title=Oxford Handbook of Infectious Diseases and Microbiology|date=2009|publisher=OUP Oxford|isbn=978-0-19-103962-1|chapter-url=https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56|language=en|chapter=Chapter 2 Antimicrobials|url-status=live|archive-url=https://web.archive.org/web/20170908143257/https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56|archive-date=8 September 2017}}</ref> Obat ini masuk dalam [[Daftar Obat Esensial Organisasi Kesehatan Dunia]].<ref name="WHO21st">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 21st list 2019 | year = 2019 | hdl = 10665/325771 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO | hdl-access=free }}</ref> Organisasi Kesehatan Dunia mengklasifikasikan linezolid sebagai obat yang sangat penting.<ref>{{cite book | vauthors=((World Health Organization)) | year=2019 | title=Critically important antimicrobials for human medicine | edition=6th revision | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | hdl=10665/312266 | isbn=9789241515528 | hdl-access=free }}</ref> Linezolid tersedia dalam bentuk [[obat generik]] di beberapa negara.<ref name=AHFS2016>{{cite web|title=Linezolid|url=https://www.drugs.com/monograph/linezolid.html|publisher=The American Society of Health-System Pharmacists|access-date=8 Desember 2016|url-status=live|archive-url=https://web.archive.org/web/20161220231329/https://www.drugs.com/monograph/linezolid.html|archive-date=20 Desember 2016}}</ref>
== Indikasi ==
Indikasi utama dari linezolid adalah untuk pengobatan infeksi berat yang disebabkan oleh [[Bakteri Gram-positif]] [[Organisme aerobik|aerobik]] yang [[resistensi antibiotik|resisten]] terhadap antibiotik lainnya. Linezolid sebaiknya tidak digunakan untuk infeksi bakteri yang masih sensitif terhadap antibiotik dengan spektrum aktivitas yang lebih sempit, seperti [[penisilin]] dan [[sefalosporin]]. Linezolid dikategorikan sebagai antibiotik lini terakhir yang hanya digunakan seperlunya untuk mencegah bakteri resisten terhadap obat ini.<ref>{{cite news |first=David |last=Wroe | name-list-format = vanc |title=An antibiotic to fight immune bugs |work=[[The Age]] |date=28 Februari 2002 |access-date=16 Mei 2009 |url=http://www.theage.com.au/articles/2002/02/27/1014704966995.html |url-status=live |archive-url=https://web.archive.org/web/20100127140624/http://www.theage.com.au/articles/2002/02/27/1014704966995.html |archive-date=27 Januari 2010 }}</ref><ref name=Wilson>{{cite journal | vauthors = Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G | title = In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients | journal = The Journal of Antimicrobial Chemotherapy | volume = 58 | issue = 2 | pages = 470–3 | date = Agustus 2006 | pmid = 16735420 | doi = 10.1093/jac/dkl233 | doi-access = free }}</ref><ref name="Bozdogan">{{cite journal | vauthors = Bozdogan B, Appelbaum PC | title = Oxazolidinones: activity, mode of action, and mechanism of resistance | journal = International Journal of Antimicrobial Agents | volume = 23 | issue = 2 | pages = 113–9 | date = Februari 2004 | pmid = 15013035 | doi = 10.1016/j.ijantimicag.2003.11.003 }}</ref>
== Cara kerja ==
|